Bio Break: Addressing Shear in Drug Delivery Device Design
In this episode of Bio Break, Joris van der Heijden and Nick Allan explore one of the most critical challenges in drug delivery device design: shear stress. When designing systems for biologics and gene therapies, avoiding shear stress is essential to ensure the viability and activity of biomolecules like proteins, antibodies, and viruses.
Joris provides a comprehensive explanation of shear, defining it as the pressure and force that can disrupt or inactivate sensitive biomolecules during fluid transport. Whether caused by abrupt fluid path changes, bubbles, or high-friction pumps, shear poses a significant risk to the efficacy of advanced therapies.
Key Takeaways from the Episode
- Understanding Shear Stress: Shear occurs when fluid is forced through abrupt changes in its path or exposed to uncontrolled movement. For biologics, shear can lead to molecule clustering or inactivation, rendering treatments ineffective.
- Design Solutions to Reduce Shear:
- Optimize Fluid Pathways: Use simulation tools like computational fluid dynamics (CFD) to identify and eliminate areas with abrupt fluid movement. Rounded pathways and smoother transitions help minimize turbulence and pressure.
- Low-Shear Pumps: Select pumps specifically designed to handle biomolecules gently, preserving their activity and integrity.
- Testing for Success: After designing a low-shear system, functional testing is critical. For example:
- Measure the viability of cells after passing through the device.
- Verify that antibodies, viruses, or other biomolecules remain active and effective post-delivery.
By addressing shear stress during the design phase, drug delivery devices can ensure biologics reach their target intact and active, maximizing therapeutic impact. For developers working with advanced therapies like gene therapy products, these design principles are essential to delivering cutting-edge care to patients.
This episode is a must-watch for engineers, product designers, and healthcare innovators seeking to tackle the complexities of drug delivery systems. Learn actionable strategies to refine your designs and improve the outcomes of sensitive therapeutics.
Addressing Shear in Drug Delivery Device Design
Related Resources
Many teams still underuse CM&S, often bringing it late in device validation, when key decisions have already been made. That approach leaves much of the value of CM&S untapped.
This article traces the Pennes bioheat equation from its 1948 origins to modern multiscale approaches, explaining how engineers select the right level of modelling complexity across device categories.
Five methods for building accurate project estimates, from gut feel to bottom-up, plus three add-ons that sharpen any estimate.
Designers and engineers today have no shortage of tools to improve designs, accelerate timelines, and meet cost targets. The challenge is knowing what to use and when.